Biotechnology Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans – Moderna (NASDAQ:MRNA) Read more
Biotechnology Moderna’s Vaccines Day 2024: A Glimpse into the Future of Infectious Disease Prevention – Moderna (NASDAQ:MRNA) Read more
Biotechnology Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Is Chart About To Form A Golden Cross? – Moderna (NASDAQ:MRNA) Read more
Biotechnology Arbutus Vs. Moderna Patent Dispute Set for Continuing Discovery – Arbutus Biopharma (NASDAQ:ABUS), Moderna (NASDAQ:MRNA) Read more
Opinion Thinking about trading options or stock in NVIDIA, Alphabet, Microsoft, Moderna, or Vertiv Holdings? – Alphabet (NASDAQ:GOOGL), Moderna (NASDAQ:MRNA) Read more
Biotechnology Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts – Moderna (NASDAQ:MRNA) Read more
Biotechnology What’s Going On With Moderna Stock On Monday? – Merck & Co (NYSE:MRK), Moderna (NASDAQ:MRNA) Read more
Biotechnology Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus – Moderna (NASDAQ:MRNA) Read more